Investigator
Tamara O'connor
JOHNS HOPKINS UNIVERSITY · funded by NIAID
- Companies
- 1
- Grants
- 3
- Non-dilutive funding
- $1.0M
- First award
- Sep 19, 2022
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest May 15, 2026.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- HEALTHPARTNERS INSTITUTE100momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R21
Manipulation of host cell peroxisomes by the bacterial pathogen Legionella
$233kMay 15, 2026NIAIDJOHNS HOPKINS UNIVERSITYNIH RePORTER · 11355719 (opens the source filing in a new tab)
- R21
Dissecting a sensory system for Legionella replication vacuole integrity
$199kMay 22, 2024NIAIDJOHNS HOPKINS UNIVERSITYNIH RePORTER · 11093470 (opens the source filing in a new tab)
- R01
Deciphering the role of peroxisomes in bacterial pathogenesis
$585kSep 19, 2022NIAIDJOHNS HOPKINS UNIVERSITYNIH RePORTER · 11131212 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources